Slide 1: Q2 2025 Financial Results
Q2 2025 Financial Results As of June 30, 2025, reported August 7, 2025 NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 1
Slide 2: Safe Harbor Statements
Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements." We have tried to identify these forward-looking statements by using words such as "may," "might," " will," "expect,” "anticipate,'' "'believe,“ "could," " intend," "plan," "estimate," "should,"
Slide 3: Sanjiv Razdan, CEO, President and Director
Sanjiv Razdan CEO, President and Director NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 3
Slide 4: Our mission is to improve quality of life through routine and affordable chiropractic care
Our mission is to improve quality of life through routine and affordable chiropractic care. Our vision is to build America’s most accessible health and wellness services company. NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 4
Slide 5: On Our Way to Becoming a Pure Play Franchisor
On Our Way to Becoming a Pure Play Franchisor 37 clinics refranchised • 31 clinics in Arizona and New Mexico • 5 clinics in Kansas City • 1 clinic in California • Actively engaged in refranchising the balance of the corporate portfolio NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 5
Slide 6: Strengthen Brand Awareness & Digital Marketing
Strengthen Brand Awareness & Digital Marketing Sharpening marketing communications to pain relief from general wellness • 80% of new patients cite aches and pains as a reason for coming to The Joint. • More relevant creative educates prospects how to get back to doing what they love • SEO optimizati
Slide 7: Initiated Dynamic Revenue Management
Initiated Dynamic Revenue Management Optimize holistic pricing while balancing affordability and patient value • More frequent, smaller price increases than past • Walk-in pricing taken in Dec. 2024; Kickstart plans started in July 2025 • Will keep exploring holistic pricing opportunities in the bal
Slide 8: Upgrading Patient-facing Technology
Upgrading Patient-facing Technology Extending the lifetime value of our patients • Launched MVP in July • 10% active patients using app in August • Working on app 2.0, including gamification NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 8
Slide 9: Scott Bowman, Chief Financial Officer
Scott Bowman Chief Financial Officer NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 9
Slide 10: Q2 2025 system-wide sales, comp sales, consolidated Adj. EBITDA
+2.6% +1.4% +52% Q2 2025 Q2 2025 Q2 2025 system-wide sales1 comp sales2 consolidated Adj. EBITA increase over Q2 2024 1 System-wide sales include revenues at all clinics, whether operated or managed by the company or by franchisees. While franchised sales are not recorded as revenues by the company,
Slide 11: Increased Franchised Clinics to 92% of Portfolio
Increased Franchised Clinics to 92% of Portfolio Reduced Regional Developer management to 52% of the clinics TOTAL CLINICS OPEN 967 967 935 82 Franchised Company-owned and managed 125 838 135 126 706 96 579 513 64 442 60 399 885 48 842 370 800 47 712 312 61 610 246 47 515 4 453 394 352 309 242 265 1
Slide 12: Q2 2025 as of Jun. 30, 2025
Q2 2025 as of Jun. 30, 2025 $ in M 1 3 mo.s 6/30/25 3 mo.s 6/30/24 Differences Revenue $13.3 $12.6 $0.7 5% Cost of revenues 2.8 2.8 0.0 (1)% Sales and marketing 3.5 3.4 0.1 1% Depreciation and amortization 0.4 0.3 0.1 18% G&A 7.7 7.8 (0.1) (1)% Operating loss (1.1) (1.8) 0.7 36% Other income 0.2 0.1
Slide 13: Strong Liquidity
Strong Liquidity $ in Ms 6/30/25 12/31/24 Unrestricted cash $29.8 $25.1 Restricted cash $1.2 $0.9 Available JP Morgan Chase LOC1 $20.0 $20.0 Stock repurchase plan: • Authorized for up to $5M of outstanding common stock • Plan authorized through June 2027 1 JPMorgan Chase LOC provides immediate acces
Slide 14: Revising 2025 Guidance
Revising 2025 Guidance Prior Prior Current Current 2024 $ in M 2025 Low 2025 High 2025 Low 2025 High Actual Guidance Guidance Guidance Guidance $530.3 $550 $570 $530 $550 System-wide sales 1 Comp sales for all clinics Mid-single digits Low-single digits open 13 months or more 2 4% Consolidated Adjus
Slide 15: Sanjiv Razdan, CEO, President and Director
Sanjiv Razdan CEO, President and Director NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 15
Slide 16: Strengthen Clinic Economics
Excel in Patient Build People Experience Capability & Culture Strengthen Clinic OUR Turbo Economics PATIENTS Charge Sales & Profits Innovate & & Reignite Broaden Relevance Growth Rapidly Grow Clinic Network 16 NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved.
Slide 17: Sandi Karrmann and Chris Grandpre, Directors
Sandi Karrmann Chris Grandpre Director Director NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 17
Slide 18: Committed to Driving Success
Committed to Driving Success System-wide Comp Net New Adjusted Sales Sales Clinic EBITDA Openings NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 18
Slide 19: Performance Metrics and Non-GAAP Measures
Performance Metrics and Non-GAAP Measures This presentation includes commonly discussed performance metrics. System-wide sales include revenues at all clinics, whether operated by the company or by franchisees. While franchised sales are not recorded as revenues by the company, management believes t
Slide 20: GAAP – Non-GAAP Reconciliation: Continuing Operations
GAAP – Non-GAAP Reconciliation Quarterly Continuing Operations NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 20
Slide 21: GAAP – Non-GAAP Reconciliation: Discontinued Operations
GAAP – Non-GAAP Reconciliation Quarterly Discontinued Operations NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 21
Slide 22: GAAP – Non-GAAP Reconciliation: Consolidated Operations
GAAP – Non-GAAP Reconciliation Quarterly Consolidated Operations NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 22
Slide 23: Contact: Sanjiv Razdan, Scott Bowman, Kirsten Chapman
Sanjiv Razdan, President & CEO sanjiv.razdan@thejoint.com sanjiv.razdan@thejoint.com The Joint Corp. | 16767 N. Perimeter Dr., Suite 110, Scottsdale, AZ 85260 | (480) 245-5960 https://www.facebook.com/thejointchiro https://www.facebook.com/thejointchiro @thejointchiro Scott Bowman, CFO https://twitt